A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastati... par G.V. Long, R. Gutzmer, A. Haydon, E. Muñoz Couselo, C. Lebbé, M. Carlino, W. Chow, F. Couture, P. Lau, F. Spagnolo, A.J. Alves Wainstein, D. Palmieri, C. Rojas García, G. de Velasco Oria de Rueda, I. Mehmi, D. Patel, A. Shaikh, N.R. Chowdhury, S. Bathena, S. Suryawanshi, P. Rutkowski

Accéder au texte intégral